Mirati Therapeutics: Q2 Earnings Insights

Mirati Therapeutics MRTX reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Mirati Therapeutics beat estimated earnings by 8.88%, reporting an EPS of $-3.18 versus an estimate of $-3.49.

Revenue was up $5.36 million from the same period last year.

Last quarter the company beat on EPS by $0.09 which was followed by a 2.56% drop in the share price the next day.

To track all earnings releases for Mirati Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.